Abstract

Cancer is one of the most diagnosed diseases in developed countries. Inflammation is a common response to different stress situations including cancer and infection. In those processes, the family of mitogen-activated protein kinases (MAPKs) has an important role regulating cytokine secretion, proliferation, survival, and apoptosis, among others. MAPKs regulate a large number of extracellular signals upon a variety of physiological as well as pathological conditions. MAPKs activation is tightly regulated by phosphorylation/dephosphorylation events. In this regard, the dual-specificity phosphatase 10 (DUSP10) has been described as a MAPK phosphatase that negatively regulates p38 MAPK and c-Jun N-terminal kinase (JNK) in several cellular types and tissues. Several studies have proposed that extracellular signal-regulated kinase (ERK) can be also modulated by DUSP10. This suggests a complex role of DUSP10 on MAPKs regulation and, in consequence, its impact in a wide variety of responses involved in both cancer and inflammation. Here, we review DUSP10 function in cancerous and immune cells and studies in both mouse models and patients that establish a clear role of DUSP10 in different processes such as inflammation, immunity, and cancer.

Highlights

  • The human genome contains a large number of genes that transcribe/translate to four families of protein tyrosine phosphatases (PTP), which are subclassified depending of their substrate, structure, regulation, and function

  • We should underline that a variety of stress stimuli such as sepsis, injury, chronic inflammation, and viral infection modulates dual-specificity phosphatase 10 (DUSP10) expression

  • DUSP10 is induced in many types of cancers, and its enhanced expression confers in general a pro-tumorigenic capacity to neoplastic cells for proliferation, migration, and differentiation

Read more

Summary

Introduction

The human genome contains a large number of genes that transcribe/translate to four families of protein tyrosine phosphatases (PTP), which are subclassified depending of their substrate, structure, regulation, and function Of these genes, 61 encode for dual-specificity phosphatase subfamily and 10 of them are catalytically active MAP kinase phosphatases (MKPs), which are able to dephosphorylate dual specificity phospho-Tyrosine (pTyr) and phospho-Threonine (pThr) substrate, and one of them is catalytically inactive MKP [1]. ISteevaenrdal tchherokminaatsien-biimndminugnodpormecaipinitaotfioDnU-mSPas1s0,sweqhuiechnccinongse(CrvHeIsPt-hseeqm) eecxhpaenriimsmenotfs mreovleeacul ltahrerebciongdninitgioonf these factors on regulatory elements of DUSP10 gene (promoter region, as identified by H3K4me binding) [19] In this regard, it has been proposed that DUSP10 gene has a particularity of being regulated by MAPKs, which promote DUSP10 expression, suggesting a negative feedback loop [20]. Current studies have demonstrated that DUSP10 is able to dephosphorylate phospho-Serine (pSer) residue of non-MAPK substrates [15]

Expression and Regulation of DUSP10
Hepatocellular and Pancreatic Cancer
Gastrointestinal Cancer
Breast Cancer
Prostate Cancer
Other Cancers and Diseases
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call